510(k) Report

510(k) · Cleared

Recalled · Class I · 2026

NOxBOXi Nitric Oxide Delivery System

K220898510(k) SpecialCleared Apr 27, 202230-day reviewClass II21 CFR 868.5165Recalls 4 (2 Class I)

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Linde Gas & Equipment, Inc. · MRN Apparatus, Nitric Oxide Delivery

Cleared on Apr 27, 2022 as substantially equivalent to K201339 (Praxair, Inc., 2020) and 1 other predicate after a 30-day review. Its family tree reaches back 7 generations to 2001. 5 of the 14 devices in its family, counting itself, have a Class I recall. 2 later devices descend from it. It has been recalled 4 times, including 2 Class I recalls.

Decided
Apr 27, 2022
Review
30 days
Class
Class II
Product code
MRN
Recalls
4 (2 Class I)
Predicates
2

Its longest line of descent runs back 7 generations to K003665 (2001). 11 ancestors in all, the oldest K000186 (2000). 2 later devices descend from it, 1 citing it directly. 5 of the 14 devices in this family, counting this one, have a Class I recall.

  1. Root · 7 generations backK003665 Fadassi Medical FM-1 NO BlenderFadasis Medical, Inc. · 2001
  2. 6 generations backK011874 Fadasis Medical FM-1 NO BlenderFadasis Medical, Inc. · 2001
  3. 5 generations backK052663 Ino Therapeutics Inoblender, Model 10004Ino Therapeutics · 2005
  4. 4 generations backK061901 Ino Therapeutics Inomax DS (Delivery System), Model 10003Ino Therapeutics · 2006 · Recalled
  5. 3 generations backK092545 Inomax DS (Delivery System), Model 10003Ino Therapeutics, LLC · 2010
  6. 2 generations backK171696 NOxBOXi Nitric Oxide Delivery SystemPraxair Distribution, Inc. · 2018 · Recalled (Class I)
  7. 1 generation backK201339 The NOxBOXi Nitric Oxide Delivery SystemPraxair, Inc. · 2020 · Recalled (Class I)
  8. This deviceK220898 NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc. · 2022
  9. Descendant · cites it directly · 1 of its ownK231823 NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc. · 2023 · Recalled (Class I)
  10. Descendant · 2 generations on · 0 of its ownK233251 NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc. · 2024 · Recalled (Class I)

Class I recalls in this family

Most influential descendants

Showing 2 of 2 · See all
  • K231823NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc. · 2023 · cites it directly1descendant
  • K233251NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc. · 2024 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K003665Fadassi Medical FM-1 NO BlenderFadasis Medical, Inc.2001—
−6K011874Fadasis Medical FM-1 NO BlenderFadasis Medical, Inc.2001—
−5K052663Ino Therapeutics Inoblender, Model 10004Ino Therapeutics2005—
−4K061901Ino Therapeutics Inomax DS (Delivery System), Model 10003Ino Therapeutics20063
−3K092545Inomax DS (Delivery System), Model 10003Ino Therapeutics, LLC2010—
−2K171696NOxBOXi Nitric Oxide Delivery SystemPraxair Distribution, Inc.2018Class I
−1K201339The NOxBOXi Nitric Oxide Delivery SystemPraxair, Inc.2020Class I
0 (this device)K220898NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc.2022—
+1K231823NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc.2023Class I
+2K233251NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc.2024Class I

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200020
200310
201210

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202311
202411
FIG. 1 — Lineage of K220898, 2001–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

5 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MRN device

  1. #1 K242374 ULSPIRA TS™ Nitric Oxide Therapy Systemscore 12.6 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K201339The NOxBOXi Nitric Oxide Delivery System
Summary page 4
…Class II Classification Panel: Anesthesiology 5. Legally Marketed Predicate Device Primary Predicate Device: NOxBOXi Nitric Oxide Delivery System K201339 Additional Predicate Device: NOxBOXi Nitric Oxide Delivery System K171696 Pa…
Praxair, Inc.2020Class I
*K171696NOxBOXi Nitric Oxide Delivery System
Summary page 4
…Marketed Predicate Device Primary Predicate Device: NOxBOXi Nitric Oxide Delivery System K201339 Additional Predicate Device: NOxBOXi Nitric Oxide Delivery System K171696 Page 1 of 6…
Praxair Distribution, Inc.2018Class I

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K231823NOxBOXi Nitric Oxide Delivery System Class ILinde Gas & Equipment, Inc.20231

Has anything in its family been recalled? (5 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Sep 14, 2026Class IIZ-3306-2026Component design/selectionPotential for irregular oxygen readings due to a manufacturing issue affecting certain oxygen sensors.
Aug 19, 2026Class IIZ-3165-2026Device DesignPotential for oxygen tubing leaks due to failure of the tubing or tubing connection, which may lead to oxygen desaturation.
Sep 9, 2025Class IZ-0028-2026Software designFluctuations may be more likely to occur if the total flow through the device sensor (used by the device to determine flow) is less than the minimum device requirement of 0.5 LPM. In addition, dose fluctuations have been observed when…
Sep 9, 2025Class IZ-0029-2026Software designThe unexpected internal fault / system diagnostic error to result when a rapid succession of button selections is made to the user interface without waiting for the device to respond to user prompts.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K201339The NOxBOXi Nitric Oxide Delivery SystemPraxair, Inc. · 2020 · Direct predicate · ◆ on the line of descent in FIG. 12 Class I recalls
  • K171696NOxBOXi Nitric Oxide Delivery SystemPraxair Distribution, Inc. · 2018 · Direct predicate · ◆ on the line of descent in FIG. 13 Class I recalls
  • K231823NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc. · 2023 · Cites it directly · ◆ in the 2023 descendants bar of FIG. 12 Class I recalls
  • K233251NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc. · 2024 · 2 generations on · ◆ in the 2024 descendants bar of FIG. 12 Class I recalls

What does this lineage say?

  • The line of descent spans 21 years and passes through 6 companies; a new generation was cleared every 1.9 years on median.
  • 4 of the 11 ancestors have a recall of any class; 2 have a Class I recall.
  • Of its descendants, K231823 (Linde Gas & Equipment, Inc., 2023) has gone furthest, with 1 descendant of its own.

How does its category compare?

All MRN devices

MRN Apparatus, Nitric Oxide Delivery: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · MRN

2in 2025

2007: 22008: 22009: 12010: 22011: 22012: 32013: 22015: 12018: 12020: 32022: 12023: 42024: 22025: 2
2007high 4 (2023) · low 0 (2014)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MRN

566in 2023

2012: 117 days median2020: 84 days median2023: 566 days median
2007high 566 (2023) · low 84 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MRN

2in 2025

2010: 22014: 12023: 12025: 2, 2 Class I2026 (partial year): 2
2007high 2 (2010) · low 0 (2007)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · MRN

155in 2025

2007: 32008: 92009: 102010: 1552011: 552012: 242013: 322014: 792015: 1562016: 942017: 1062018: 1382019: 1442020: 1992021: 2212022: 1152023: 992024: 1382025: 155
2007high 221 (2021) · low 3 (2007)2025

MAUDE reports naming product code MRN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—03
20082—09
20091—010
20102—2155
20112—055
20123117024
20132—032
20140—179
20151—0156
20160—094
20170—0106
20181—0138
20190—0144
20203840199
20210—0221
20221—0115
20234566199
20242—0138
20252—2 (2)155
20260—2—

What is it indicated for?

NOxBOXi Nitric Oxide Delivery System is intended for use by healthcare professionals for the delivery and monitoring of a constant (user set) concentration of nitric oxide (NO) and the monitoring of N02 and 02 in the inspiratory ventilator lines of a patient undergoing nitric oxide therapy (iNO). The NOxBOXi Nitric Oxide Delivery System includes: * The NOxBOXi head unit, which delivers NO gas while in the intelligent delivery mode. * Continuous…

Read the full statement (156 words)

NOxBOXi Nitric Oxide Delivery System is intended for use by healthcare professionals for the delivery and monitoring of a constant (user set) concentration of nitric oxide (NO) and the monitoring of N02 and 02 in the inspiratory ventilator lines of a patient undergoing nitric oxide therapy (iNO).

The NOxBOXi Nitric Oxide Delivery System includes:

* The NOxBOXi head unit, which delivers NO gas while in the intelligent delivery mode.

* Continuous monitoring and alarms for NO, 02 and N02.

* The integrated NOxMixer which provides a backup NO delivery capability that is intended to deliver a continuous flow of NO, mixed with 02, for iNO therapy and provides a continuous treatment option during transit and transfer conditions within hospitals.

The NOxBOXiNitric Oxide Delivery System must only be used in accordance with the indications, contraindications, warnings and precautions described in the nitric oxide drug packaging inserts and labeling (currently neonates). Refer to this material prior to use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K220898: NOxBOXi Nitric Oxide Delivery System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K220898

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026